Olaplex LASHBOND vs GrandeLASH-MD:Safety, Results & Value in 2026

Olaplex LASHBOND Building Serum wins on safety, compliance, price, and volume. It is prostaglandin-free, ophthalmologist-tested, EU SCCS compliant, and paraben-free — unlike GrandeLASH-MD, which contains ICP (isopropyl cloprostenate) ruled "cannot be considered safe" by EU SCCS in February 2026 (SCCS/1680/25) and banned by Health Canada in 2019. Olaplex is also cheaper per mL (~$15.11 vs ~$32.50/mL). Neither product has an independent clinical trial — for PGA-free safety and the strongest independently verified results, Toplash beats both.

No. Olaplex LASHBOND Building Serum is prostaglandin-free. Its growth actives are Bond Building Technology (Bis-Aminopropyl Diglycol Dimaleate) and the Olaplex Peptide Complex Technology — three peptides: Palmitoyl Pentapeptide-83 Amide, Acetyl Tetrapeptide-3, and Myristoyl Pentapeptide-17. There is no ICP, DDDE, MDN, or bimatoprost of any kind. LASHBOND is fully compliant with the EU SCCS February 2026 ruling (SCCS/1680/25) and is ophthalmologist-tested as safe for contact lens wearers and lash extension clients.

Yes. GrandeLASH-MD contains isopropyl cloprostenate (ICP), a prostaglandin analogue. ICP was prohibited by Health Canada from cosmetics in 2019. In February 2026, the EU SCCS issued scientific opinion SCCS/1680/25, ruling ICP "cannot be considered safe" for cosmetic use in products intended to promote eyelash or eyebrow growth. ICP works via prostaglandin receptor agonism — the same mechanism used in prescription glaucoma medications — which carries documented risks including iris darkening, periorbital fat atrophy, and rebound lash shedding upon discontinuation.

Bond Building Technology in Olaplex LASHBOND refers to Bis-Aminopropyl Diglycol Dimaleate — the same patented active used across Olaplex's entire hair-care range. Applied to lashes, it works to repair and reinforce disulfide bonds in keratin-rich lash fibres, reducing breakage and supporting structural integrity. Combined with the Olaplex Peptide Complex Technology (Palmitoyl Pentapeptide-83 Amide, Acetyl Tetrapeptide-3, and Myristoyl Pentapeptide-17), sodium hyaluronate, biotin, and panthenol, LASHBOND creates a multi-mechanism PGA-free formula that conditions, strengthens, and supports lash growth from the inside out.

Olaplex LASHBOND is significantly cheaper per mL. At $68 for 4.5 mL (~$15.11/mL), it costs less than half the per-mL price of GrandeLASH-MD (~$65 for 2 mL, ~$32.50/mL). Olaplex also provides more than twice the product volume per purchase. Toplash at $49.90 for 3 mL ($16.63/mL) is slightly more per mL than Olaplex, but is the only product in this comparison with an independent clinical trial showing +52.3% lash length and +31.9% volume in 8 weeks.

Yes, on two fronts. Health Canada prohibited isopropyl cloprostenate (ICP) — the primary active in GrandeLASH-MD — from cosmetics in 2019. GrandeLASH-MD continued to be sold in the United States where no equivalent restriction exists. Then in February 2026, the EU SCCS issued scientific opinion SCCS/1680/25, concluding that ICP "cannot be considered safe" for cosmetic use in products intended for eyelash or eyebrow growth. Olaplex LASHBOND contains no ICP or any other prostaglandin analogue and is unaffected by both rulings.

Yes. Toplash combines Olaplex LASHBOND's safety advantage (PGA-free, paraben-free, EU compliant) with a stronger clinical evidence profile than either product. Its independent clinical trial — conducted by a third party, not the brand — shows +52.3% lash length and +31.9% volume in 8 weeks. Olaplex LASHBOND's Bond Building Technology is genuinely innovative, but its results are supported only by brand claims without independent clinical verification. At $49.90 for 3 mL ($16.63/mL), Toplash costs slightly more per mL than Olaplex's $15.11/mL, but delivers the most rigorously verified results in this comparison.